<DOC>
	<DOCNO>NCT01228747</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety tolerability levetiracetam treatment use adjunctive therapy Japanese Chinese epilepsy patient age â‰¥16 year uncontrolled Generalized Tonic-Clonic seizure despite treatment 1 2 anti-epileptic drug .</brief_summary>
	<brief_title>A Double-blind , Placebo-controlled Study Levetiracetam Epilepsy Patients With Generalized Tonic-clonic Seizures ( Except Partial Seizures Evolving Secondarily Generalized Seizures )</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>An epilepsy patient generalize tonicclonic seizure classifiable accord ILAE classification epileptic seizure ( Epilepsia , 1981 ) A patient stable dose 1 2 antiepileptic drug last 4 week ( potassium bromide sodium bromide last 12 week ) prior combine baseline period Presence sign ( clinical imaging procedure ) suggest progressive brain lesion/disease , particular , progressive disorder epileptic seizure Diagnosis LennoxGastaut Syndrome Confirmed focal epilepsy base clinical sign ( seizure type ) , consistent electroencephalogram magnetic resonance imagining feature A history convulsive nonconvulsive status epilepticus take concomitant antiepileptic drug last 3 month prior Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Levetiracetam</keyword>
	<keyword>epilepsy</keyword>
	<keyword>generalize tonic-clonic</keyword>
</DOC>